Lisinopril Tablets USP

/Lisinopril Tablets USP
Lisinopril Tablets USP2018-09-06T09:12:40+00:00

Prescription Drug Name:

Lisinopril Tablets USP

ID:

b6067e83-6c20-4902-84db-cf26f1c3c005

Code:

34391-3

DESCRIPTION


id: 3535a26d-7088-479b-8985-cf2856764c72
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3

Lisinopril is an oral long-acting angiotensin converting enzyme inhibitor. Lisinopril, a synthetic peptide derivative, is chemically described as (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate. Its empirical formula is C21H31N3O5(2H2O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.53. It is soluble in water and sparingly soluble in methanol and practically insoluble in ethanol. Lisinopril tablets are supplied as 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg tablets for oral administration. Inactive Ingredients: 2.5 mg tablets – colloidal silicon dioxide, dibasic calcium phosphate, magnesium stearate, mannitol, pre-gelatinized starch, starch. 5 mg, 10 mg, 20 mg and 30 mg tablets – colloidal silicon dioxide, dibasic calcium phosphate, magnesium stearate, mannitol, pre-gelatinized starch, red iron oxide, starch. 40 mg tablets – colloidal silicon dioxide, dibasic calcium phosphate, magnesium stearate, mannitol, pre-gelatinized starch, starch, yellow iron oxide.

CONTRAINDICATIONS


id: fb5f9cc9-2248-4080-8262-aa7b0bd08934
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3

Lisinopril is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema.

ADVERSE REACTIONS


id: 9fa64aa2-6411-48ed-add5-e4c468ac0cbb
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4

Lisinopril has been found to be generally well tolerated in controlled clinical trials involving 1969 patients with hypertension or heart failure. For the most part, adverse experiences were mild and transient.

OVERDOSAGE


id: a0f05871-5b9e-45c3-bd78-4ea4cb1d5b00
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5

Following a single oral dose of 20 g/kg no lethality occurred in rats, and death occurred in one of 20 mice receiving the same dose. The most likely manifestation of overdosage would be hypotension, for which the usual treatment would be intravenous infusion of normal saline solution. Lisinopril can be removed by hemodialysis (See WARNINGS, Anaphylactoid Reactions During Membrane Exposure).

HOW SUPPLIED


id: 862689a5-fd1d-43e6-8ced-cf24c8574a5d
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5

Lisinopril Tablets, USP are available as: 2.5 mg tablet is a white to off-white, round, biconvex uncoated tablet with ‘LUPIN” debossed on one side and “2.5” on other side. They are available as follows: Bottles of 90              NDC 68180-512-09 Bottles of 100            NDC 68180-512-01 Bottles of 500            NDC 68180-512-02 Bottles of 1000          NDC 68180-512-03 5 mg tablet is a pink coloured, round, biconvex uncoated tablet with “5” debossed on one side and breakline on other side. They are available as follows: Bottles of 90              NDC 68180-513-09 Bottles of 100            NDC 68180-513-01 Bottles of 500            NDC 68180-513-02 Bottles of 1000          NDC 68180-513-03 Bottles of 5000          NDC 68180-513-05 10 mg tablet is a pink coloured, round, biconvex uncoated tablet with “LUPIN” debossed on one side and “10” on other side. They are available as follows: Bottles of 90              NDC 68180-514-09 Bottles of 100            NDC 68180-514-01 Bottles of 500            NDC 68180-514-02 Bottles of 1000          NDC 68180-514-03 Bottles of 5000          NDC 68180-514-05 20 mg tablet is a pink coloured, round, biconvex uncoated tablet with “LUPIN” debossed on one side and “20” on other side. They are available as follows: Bottles of 90              NDC 68180-515-09 Bottles of 100            NDC 68180-515-01 Bottles of 500            NDC 68180-515-02 Bottles of 1000          NDC 68180-515-03 Bottles of 5000          NDC 68180-515-05 30 mg tablet is a red coloured, round, biconvex uncoated tablet with “LUPIN” debossed on one side and “30” on other side. They are available as follows: Bottles of 90              NDC 68180-516-09 Bottles of 100            NDC 68180-516-01 Bottles of 500            NDC 68180-516-02 Bottles of 1000          NDC 68180-516-03 40 mg tablet is a yellow coloured, round, biconvex uncoated tablet with “LUPIN” debossed on one side and “40” on other side. They are available as follows: Bottles of 90              NDC 68180-517-09 Bottles of 100            NDC 68180-517-01 Bottles of 500            NDC 68180-517-02 Bottles of 1000          NDC 68180-517-03 Bottles of 2000          NDC 68180-517-04 Storage: Store at 20º to 25ºC (68º to 77ºF)[see USP Controlled Room Temperature]. Protect from moisture, freezing and excessive heat. Dispense in a tight container.

PRINCIPAL DISPLAY PANEL


id: 7276004d-7e87-4e97-8320-812742189e35
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4